146 related articles for article (PubMed ID: 2821143)
21. Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.
Dray A; Nunan L; Wire W
Br J Pharmacol; 1985 Jul; 85(3):717-26. PubMed ID: 2992671
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
[TBL] [Abstract][Full Text] [Related]
23. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility.
Dray A; Metsch R
Eur J Pharmacol; 1984 Sep; 104(1-2):47-53. PubMed ID: 6094211
[TBL] [Abstract][Full Text] [Related]
24. Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions.
Evans RG; Ludbrook J; Van Leeuwen AF
J Physiol; 1989 Dec; 419():15-31. PubMed ID: 2559974
[TBL] [Abstract][Full Text] [Related]
25. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
Kirby GC; McQueen DS
Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
[TBL] [Abstract][Full Text] [Related]
26. The antinociceptive role of mu- and delta-opiate receptors and their interactions in the spinal dorsal horn of cats.
Omote K; Kitahata LM; Collins JG; Nakatani K; Nakagawa I
Anesth Analg; 1990 Jul; 71(1):23-8. PubMed ID: 1973027
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes.
Daugé V; Rossignol P; Roques BP
Psychopharmacology (Berl); 1988; 96(3):343-52. PubMed ID: 2851851
[TBL] [Abstract][Full Text] [Related]
28. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
[TBL] [Abstract][Full Text] [Related]
29. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.
Daugé V; Rossignol P; Roques BP
Psychopharmacology (Berl); 1989; 99(2):168-75. PubMed ID: 2572028
[TBL] [Abstract][Full Text] [Related]
30. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
31. mu-Opioid peptide modulation of cardiovascular and sympathoadrenal responses to stress.
Marson L; Kiritsy-Roy JA; Van Loon GR
Am J Physiol; 1989 Oct; 257(4 Pt 2):R901-8. PubMed ID: 2552846
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of oxytocin secretion by mu and delta receptor selective enkephalin analogues.
Wright DM; Clarke G
Neuropeptides; 1984 Dec; 5(1-3):273-6. PubMed ID: 6099511
[TBL] [Abstract][Full Text] [Related]
33. Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins.
Meucci E; Delay-Goyet P; Roques BP; Zajac JM
Eur J Pharmacol; 1989 Nov; 171(2-3):167-78. PubMed ID: 2559856
[TBL] [Abstract][Full Text] [Related]
34. The electrically stimulated release of [3H]noradrenaline from nucleus tractus solitarii slices in vitro is modulated via mu-opioid receptors.
Arakawa K; De Jong W; Mulder AH; Versteeg DH
Eur J Pharmacol; 1991 Jan; 192(2):311-6. PubMed ID: 1674475
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
[TBL] [Abstract][Full Text] [Related]
36. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
[TBL] [Abstract][Full Text] [Related]
37. A comparative study in rats of the respiratory depression and analgesia induced by mu- and delta-opioid agonists.
Pazos A; Flórez J
Eur J Pharmacol; 1984 Mar; 99(1):15-21. PubMed ID: 6373310
[TBL] [Abstract][Full Text] [Related]
38. Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.
Dray A; Nunan L; Wire W
J Pharmacol Exp Ther; 1985 Dec; 235(3):670-6. PubMed ID: 3001272
[TBL] [Abstract][Full Text] [Related]
39. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
Fang FG; Fields HL; Lee NM
J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
[TBL] [Abstract][Full Text] [Related]
40. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
Noble F; Smadja C; Roques BP
J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
